Naltrexone Treatment Centers in Missouri

For methadone and buprenorphine, continued opioid use during induction is common and expected; the medication itself helps stop use. For naltrexone, however, you must complete a 7–14 day opioid-free period first. Your Missouri clinician will tailor the induction based on your medication.

It depends on the program. Bundled MAT programs include counseling in a single weekly or monthly fee. Others bill counseling separately ($40–$150 per session). MO HealthNet and most commercial plans cover both components when delivered by a licensed provider.

Yes. MO HealthNet covers Sublocade and Vivitrol as part of the MAT benefit; most plans require prior authorization documenting prior MAT adherence. Billing is handled by the Missouri provider as a medical (not pharmacy) benefit.

Yes — under the Mental Health Parity and Addiction Equity Act and the Affordable Care Act, marketplace and employer health plans must cover MAT for OUD, including naltrexone. Specific cost-sharing (copay, coinsurance, deductible) depends on your plan tier.

Yes — federal Congress eliminated the X-waiver in December 2022, so any Missouri clinician with a DEA registration can now prescribe buprenorphine for OUD. Continuing-education requirements apply; training is free through Providers Clinical Support System (PCSS) and SAMHSA.

Yes. Meta-analyses consistently find that patients who remain on MAT longer than 12 months have lower rates of relapse, infectious disease, and overdose death. Missouri Medicaid-funded programs report improved retention with long-acting injectables compared to sublingual treatment.

For methadone and buprenorphine, continued opioid use at entry is expected — the medication is designed to stop use safely. For naltrexone, 7–14 opioid-free days are required first. Your Missouri clinician will confirm the correct induction strategy at intake.

Usually yes. Missouri programs following low-barrier protocols provide the first buprenorphine dose or naltrexone prescription on day one. Methadone first doses are administered in-clinic and require SAMHSA-certified protocols that are typically completed during the intake visit.

Methadone can prolong the QTc interval on ECG; Missouri clinics screen patients with baseline and follow-up ECGs. Buprenorphine and naltrexone do not carry this risk. Patients with cardiac disease can safely use MAT under close cardiology and MAT-team coordination.

Missouri has specific protocols: prenatal MAT under medical supervision is typically not grounds for child-welfare action on its own. Hospital social workers may coordinate a Plan of Safe Care as required by CAPTA — this is a supportive plan, not automatic removal.

Sessions cover craving management, relapse-prevention skills, coping strategies, relationship issues, trauma processing if relevant, and goal setting for recovery. The counselor and client collaborate on a written treatment plan that is updated every 30–90 days in Missouri.

Yes. Group members sign confidentiality agreements, and the clinician protects group content under 42 CFR Part 2. Enforcement between group members depends on honor among peers, but legal protections limit disclosure by the clinic or clinician.